Preliminary evidence supporting the safety of drug-eluting stents in neurovascular disease

REFERENCES

• Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group. Prognosis of patients with symptomatic vertebral or basilar artery stenosis. Stroke 1998; 29: 1389–1392
   PubMed Web of Science ®Google Scholar
• Petty GW, Brown RD Jr, Whisnant JP, et al. Ischemic stroke subtypes : a population-based study of functional outcome, survival, and recurrence. Stroke 2000; 31: 1062–1068
   PubMed Web of Science ®Google Scholar
• Connors JJ III, Wojak JC. Intracranial angioplasty. J Invas Cardiol 1998; 10 (5): 298–303
   PubMed Web of Science ®Google Scholar
• Ausman JJ, Diaz FG, Pearce JE, et al. Endarterectomy of the vertebral artery from C2 to posterior inferior cerebellar artery i ntrac ran ia I I y. Surg Neurol 1982; 18 (6): 400–404
   PubMedGoogle Scholar
• Ausman JJ, Diaz FG, Sadasivan B, et al. Intracranial vertebral endarterectomy. Neurosurgery 1990; 26: 465–471
   PubMed Web of Science ®Google Scholar
• Ausman JJ, Diaz FG, Vacca DF, et al. Superficial temporal and occipital artery bypass pedicles to superior, anterior inferior, and posterior inferior cerebellar arteries for vertebrobasilar insuffi-ciency. I Neurosurg 1990; 72: 554–558
   PubMed Web of Science ®Google Scholar
• Ausman JJ, laz FG. Microsurgical reconstruction of the posterior circulation. Otolaryngol Head Neck Surg 1984; 92: 102–108
   PubMed Web of Science ®Google Scholar
• Ausman JJ, Nicoloff DM, Chou SN. Posterior fossa revasculariza-tion: anastomosis of vertebral artery to PICA with interposed radial artery graft. Surg Neurol 1978; 9 (5): 281–286
   PubMedGoogle Scholar
• Ausman JJ, Shrontz CE, Pearce JE, et al. Vertebrobasilar insuffi-ciency. A review. Arch Neurol 1985; 42: 803–808
   PubMedGoogle Scholar
• Connors JJ III, Wojak JC. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. ] Neurosurg 1999; 91: 415–423
   PubMed Web of Science ®Google Scholar
• SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004; 35: 1388–1392
   PubMed Web of Science ®Google Scholar
• Vrolix MC, Legrand VM, Reiber JH, et al. Heparin-coated Wiktor stents in human coronary arteries (MENTOR trial). MENTOR Trial Investigators. Am] Cardiol 2000; 86 (4): 385–389
   PubMed Web of Science ®Google Scholar
• Gupta V, Aravamuthan BR, Baskervil le S, et al. Reduction of subacute stent thrombosis (SAT) using heparin-coated stents in a large-scale, real world registry. J Invas Cardiol 2004; 16 (6): 304–310
   PubMedGoogle Scholar
• Mehran R, Aymong ED, Ashby DT, et al. Safety of an aspirin-alone regimen after intracoronary stenting with a heparin-coated stent: final results of the HOPE (HEPACOAT and an Antithrombotic Regimen of Aspirin Alone) Study. Circulation 2003; 108: 1078–1083
   PubMed Web of Science ®Google Scholar
• Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773–1780
   PubMed Web of Science ®Google Scholar
• Stone GW, Ellis SG, Cox DA, et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation 2004; 109: 1942–1947
   PubMed Web of Science ®Google Scholar
• Levy El, Boulos AS, Hanel RA, et al. In vivo model of intracranial stent implantation: a pilot study to examine the histological response of cerebral vessels after randomized implantation of heparin-coated and uncoated endoluminal stents in a blinded fashion. J Neurosurg 2003; 98: 544–553
   PubMed Web of Science ®Google Scholar
• Levy El, Hanel RA, Howington JU, et al. Sirolimus-eluting stents in the canine cerebral vasculature: a prospective, randomized, blinded assessment of safety and vessel response. I Neurosurg 2004; 100: 688–694
   PubMed Web of Science ®Google Scholar
• Misra M, Alp MS, Hier D, et al. Multidisciplinary treatment of posterior circulation ischemia. Neurol Res 2004; 26: 67–73
   PubMed Web of Science ®Google Scholar
• Woods TC, Marks AR. Drug-eluting stents. Ann Rev Med2004; 55: 169–178
   PubMed Web of Science ®Google Scholar
• Mori T, Kazita K, Mori K. Cerebral angioplasty and stenting for intracranial vertebral atherosclerotic stenosis. Am J Neurol Res Am I Neuroradiol 1999; 20: 787–789
   PubMed Web of Science ®Google Scholar
• Morris PP, Martin EM, Regan J, et al. Intracranial deployment of coronary stents for symptomatic atherosclerotic disease. Am I Neurol Res Am] Neuroradiol 1999; 20: 1688–1694
   PubMed Web of Science ®Google Scholar
• Gomez CR, Orr SC. Angioplasty and stenting for primary treatment of intracranial arterial stenoses. Arch Neurol 2001; 58: 1687–1690
   PubMedGoogle Scholar
• Levy El, Hanel RA, Bendok BR, et al. Staged stent-assisted angioplasty for symptomatic intracranial vertebrobasilar artery stenosis. I Neurosurg 2002; 97: 1294–1301
   PubMed Web of Science ®Google Scholar
• Whitaker JN. Medical and endovascular therapy for intracranial atherosclerotic vascular disease. Arch Neurol 2001; 58: 1692-1693
   Google Scholar
• Levy El, Hanel RA, Boulos AS, et al. Comparison of periprocedure complications resulting from direct stent placement compared with those due to conventional and staged stent placement in the basilar artery. ] Neurosurg 2003; 99: 653–660
   PubMed Web of Science ®Google Scholar
• de Rochemont Rdu M, Turowski B, Buchkremer M, et al. Recurrent symptomatic high-grade intracranial stenoses: safety and efficacy of under-sized stents—initial experience. Radiology 2004; 231: 45–49
   PubMed Web of Science ®Google Scholar
• Pieniazek P, Musialek P, Motyl R, et al. Use of the Parodi Anti-Emboli System and transient subclavian steal for cerebral protec-tion during emergent vertebral artery recanalization. I Endovasc Ther 2004; 11: 511–516
   PubMed Web of Science ®Google Scholar
• Mintz EP, Gruberg L, Kouperberg E, et al. Vertebral artery stenting using distal emboli protection and transcranial Doppler. Catheter Cardiovasc Interv 2004; 61: 12–15
   PubMed Web of Science ®Google Scholar
• Albuquerque FC, Fiorella D, Han P, et al. A reappraisal of angioplasty and stenting for the treatment of vertebral origin stenosis. Neurosurgery 2003; 53: 607–614
   PubMed Web of Science ®Google Scholar
• Serruys PW, Ormiston JA, Sianos G, et al. Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial. I Am Coll Cardiol 2004; 44: 1363–1367
   PubMed Web of Science ®Google Scholar
• Buellesfeld L, Grube E. ABT-578-eluting stents. The promising successor of sirolimus- and paclitaxel-eluting stent concepts? Herz 2004; 29: 167–170
   Google Scholar